風疹診断検査の世界市場レポート 2025年

風疹診断検査市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.5％で17億9,000万米ドルに成長します。予測期間の成長は、ヘルスケア支出の増加、予防医療への注目の高まり、ワクチンで予防可能な病気に対する意識の高まり、公衆衛生キャンペーンの拡大、遠隔医療と遠隔診断の拡大に起因しています。予測期間における主な動向としては、診断技術の進歩、ヘルスケアシステムにおける技術統合、ポイントオブケア検査ソリューションの開発、新しい診断方法の開発、分子診断の進歩などが挙げられます。

ウイルス感染症の罹患率の増加が、今後の風疹診断検査市場の成長を牽引すると予測されます。ウイルス感染症は、ウイルスによって引き起こされる病気であり、ウイルスは宿主生物の生きた細胞内でのみ複製可能な小さな感染性因子です。ウイルス感染症の増加は、ウイルスの国境を越えた急速な拡散を可能にする世界の旅行の増加と、媒介生物の生息地を変更し、病気を媒介する生物の分布を拡大する気候変動に起因しています。風疹診断検査は、風疹感染の早期発見と管理、特に妊婦における合併症の予防、そしてウイルスのトランスミッションを最小化するためのアウトブレイクコントロールの促進に極めて重要です。例えば、2023年12月、英国の政府機関である国民保健サービス（National Health Service）は、インフルエンザによる1日平均234件の入院患者を報告し、前週から53％増加しました。また、ノロウイルスの入院患者数は15％増加し、1日平均406人で、これは前年同週と比較して28％の増加です。その結果、ウイルス感染症例の増加が風疹診断検査市場の成長を促進しています。

風疹診断検査市場の主要企業は、診断精度の向上と予防対策の強化のため、風疹ウイルスワクチンなどの革新的ソリューションの開発に注力しています。風疹ウイルスワクチンは風疹に対する免疫を提供し、病気やその合併症を予防するためにMMRやMMRV混合ワクチンに含まれることが多いです。例えば、米国を拠点とする製薬会社Merck &Co., Inc.は2023年3月、風疹だけでなく麻疹や流行性耳下腺炎の予防にも不可欠なM-M-R IIワクチンの筋肉内（IM）投与についてFDAの承認を取得しました。この承認により、ヘルスケアプロバイダーは風疹ワクチンをIMルートで投与できるようになり、他の定期的に推奨される小児用ワクチンと並ぶことになります。風疹に対するワクチン接種は、流行を予防し、特に妊婦において風疹ウイルスが引き起こす可能性のある重篤な合併症から守るために極めて重要です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界風疹診断検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の風疹診断検査市場：成長率分析
• 世界の風疹診断検査市場の実績：規模と成長, 2019-2024
• 世界の風疹診断検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界風疹診断検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の風疹診断検査市場診断技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ラテックス凝集反応
• 肝機能検査
• 酵素免疫測定（EIA）
• ラジオイムノアッセイ（RIA）
• 蛍光免疫測定（FIA）
• その他の診断技術
• 世界の風疹診断検査市場：年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 新生児
• ティーンエイジャー
• 大人
• 世界の風疹診断検査市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• がん診断センター
• 外来手術センター
• その他のエンドユーザー
• 世界の風疹診断検査市場ラテックス凝集反応の種類によるサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 定性ラテックス凝集試験
• 定量ラテックス凝集試験
• 迅速ラテックス凝集キット
• 世界の風疹診断検査市場肝機能検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血清ビリルビン検査
• アラニンアミノトランスフェラーゼ（ALT）検査
• アスパラギン酸アミノトランスフェラーゼ（AST）検査
• アルカリホスファターゼ（ALP）検査
• その他の肝酵素検査
• 世界の風疹診断検査市場酵素免疫測定（EIA）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 直接環境影響評価
• 間接環境影響評価
• サンドイッチEIA
• 競争的環境影響評価
• 世界の風疹診断検査市場ラジオイムノアッセイ（RIA）のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標準RIA
• 修正RIA
• 単一抗体RIA
• 世界の風疹診断検査市場蛍光免疫測定（FIA）のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 直接FIA
• 間接FIA
• サンドイッチFIA
• 世界の風疹診断検査市場、その他の診断技術の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリメラーゼ連鎖反応（PCR）
• 核酸増幅検査（NAAT）
• マイクロプレートベースのアッセイ
• ウェスタンブロッティング

第7章 地域別・国別分析

• 世界の風疹診断検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の風疹診断検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 風疹診断検査市場：競合情勢
• 風疹診断検査市場：企業プロファイル
  • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• bioMerieux S.A.
• Bio-Rad Laboratories Inc.
• Ortho-Clinical Diagnostics Inc.
• DiaSorin S.p.A.
• Meridian Bioscience Inc.
• Fortress Diagnostics Ltd.
• Mylab Discovery Solutions Pvt. Ltd.
• MP Biomedicals LLC
• CTK Biotech Inc.
• ZEUS Scientific Inc.
• Creative Diagnostics
• Arlington Scientific Inc.
• AccuBioTech Co. Ltd.
• Intec Products Inc.
• Vitrosens Biotechnology Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 風疹診断検査市場2029：新たな機会を提供する国
• 風疹診断検査市場2029：新たな機会を提供するセグメント
• 風疹診断検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Rubella diagnostic testing involves methods used to detect the presence of the rubella virus or antibodies in a patient's blood, confirming whether they have been infected with rubella or possess immunity against it. These tests enable healthcare providers to accurately diagnose rubella and manage its implications, particularly for vulnerable populations.

The primary types of diagnostic techniques used in rubella testing include latex agglutination, liver function tests, enzyme immunoassay (EIA), radioimmunoassay (RIA), fluorescent immunoassay (FIA), and others. Latex agglutination is a diagnostic approach where small latex beads coated with rubella-specific antigens or antibodies are mixed with a patient's sample. This technique can be applied across various age groups, including neonates, teenagers, and adults, serving a wide range of end users such as hospitals, clinics, cancer diagnostic centers, and ambulatory surgical centers.

The rubella diagnostic testing market research report is one of a series of new reports from The Business Research Company that provides rubella diagnostic testing market statistics, including rubella diagnostic testing industry global market size, regional shares, competitors with a rubella diagnostic testing market share, detailed rubella diagnostic testing market segments, market trends and opportunities, and any further data you may need to thrive in the rubella diagnostic testing industry. This rubella diagnostic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rubella diagnostic testing market size has grown strongly in recent years. It will grow from $1.3 billion in 2024 to $1.39 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to a rise in vaccination programs, a rising incidence of immunization-preventable outbreaks, government initiatives to combat the rubella virus, and the expansion of diagnostic testing in non-traditional settings.

The rubella diagnostic testing market size is expected to see strong growth in the next few years. It will grow to $1.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing healthcare expenditure, growing focus on preventive healthcare, rising awareness of vaccine-preventable diseases, growing public health campaigns, and expansion of telemedicine and remote diagnostics. Major trends in the forecast period include advancements in diagnostic technologies, technological integration in healthcare systems, development of point-of-care testing solutions, development of new diagnostic methods, and advancements in molecular diagnostics.

The increasing incidence of viral infections is anticipated to drive the growth of the rubella diagnostic testing market in the future. Viral infections are illnesses caused by viruses, which are tiny infectious agents that can only replicate within the living cells of a host organism. The rise in viral infections can be attributed to heightened global travel, which allows for the rapid spread of viruses across borders, as well as climate change, which modifies vector habitats and expands the distribution of disease-carrying organisms. Rubella diagnostic testing is crucial for early identification and management of rubella infections, helping to prevent complications, especially in pregnant women, and facilitating outbreak control to minimize virus transmission. For instance, in December 2023, the National Health Service, a UK government department, reported an average of 234 daily hospital admissions for flu, representing a 53% increase from the previous week. Additionally, hospital cases of norovirus rose by 15%, averaging 406 daily, which is a 28% increase compared to the same week last year. Consequently, the increasing cases of viral infections are propelling the growth of the rubella diagnostic testing market.

Key companies in the rubella diagnostic testing market are concentrating on developing innovative solutions, such as rubella virus vaccines, to improve diagnostic accuracy and enhance preventive measures. The rubella virus vaccine provides immunity against rubella and is often included in the MMR or MMRV combination vaccines to prevent the disease and its complications. For example, in March 2023, Merck & Co., Inc., a U.S.-based pharmaceutical company, received FDA approval for the intramuscular (IM) administration of its M-M-R II vaccine, which is essential for protecting against rubella, as well as measles and mumps. This approval enables healthcare providers to administer the rubella vaccine via the IM route, aligning it with other routinely recommended pediatric vaccines. Vaccination against rubella is critical for preventing outbreaks and safeguarding against the severe complications that the virus can inflict, particularly in pregnant women.

In September 2024, Leinco Technologies Inc., a U.S.-based developer of high-purity antibodies, acquired QED Biosciences for an undisclosed sum. This acquisition aims to expand Leinco Technologies' antibody product portfolio and development services, enhancing its capabilities in life sciences and in vitro diagnostics while supporting its growth strategy and commitment to innovation and quality for researchers worldwide. QED Biosciences specializes in developing novel monoclonal and polyclonal antibody products and offers rubella diagnostic testing services.

Major companies operating in the rubella diagnostic testing market are Cardinal Health Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMerieux S.A., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin S.p.A., Meridian Bioscience Inc., Fortress Diagnostics Ltd., Mylab Discovery Solutions Pvt. Ltd., MP Biomedicals LLC, CTK Biotech Inc., ZEUS Scientific Inc., Creative Diagnostics, Arlington Scientific Inc., AccuBioTech Co. Ltd., Intec Products Inc., Vitrosens Biotechnology Ltd., Sprint Diagnostics Pvt. Ltd., InDevR Inc., Atlas Medical GmbH

North America was the largest region in the rubella diagnostic testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rubella diagnostic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rubella diagnostic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The rubella diagnostic testing market consists of revenues earned by entities by providing services such as serological testing services, serologic tests, molecular diagnostic services, and rapid diagnostic testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The rubella diagnostic testing market also includes sales of serological assays, IgM antibodies, rapid diagnostic tests (RDTs), and polymerase chain reaction (PCR) tests. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rubella Diagnostic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rubella diagnostic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rubella diagnostic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rubella diagnostic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Diagnostic Technique: Latex Agglutination; Liver Function Tests; Enzyme Immunoassay (EIA); Radioimmunoassay (Ria); Fluorescent Immunoassay (FIA); Other Diagnostic Techniques
• 2) By Age Group: Neonates; Teenagers; Adults
• 3) By End User: Hospitals And Clinics; Cancer Diagnostic Centers; Ambulatory Surgical Centers; Other End Users
• Subsegments:
• 1) By Latex Agglutination: Qualitative Latex Agglutination Tests; Quantitative Latex Agglutination Tests; Rapid Latex Agglutination Kits
• 2) By Liver Function Tests: Serum Bilirubin Tests; Alanine Aminotransferase (ALT) Tests; Aspartate Aminotransferase (AST) Tests; Alkaline Phosphatase (ALP) Tests; Other Liver Enzyme Tests
• 3) By Enzyme Immunoassay (EIA): Direct EIA; Indirect EIA; Sandwich EIA; Competitive EIA
• 4) By Radioimmunoassay (RIA): Standard RIA; Modified RIA; Single-Antibody RIA
• 5) By Fluorescent Immunoassay (FIA): Direct FIA; Indirect FIA; Sandwich FIA
• 6) Other Diagnostic Techniques: Polymerase Chain Reaction (PCR); Nucleic Acid Amplification Tests (NAAT); Microplate-Based Assays; Western Blotting
• Companies Mentioned: Cardinal Health Inc.; Siemens Healthineers AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; F. Hoffmann-La Roche Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Rubella Diagnostic Testing Market Characteristics

3. Rubella Diagnostic Testing Market Trends And Strategies

4. Rubella Diagnostic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Rubella Diagnostic Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Rubella Diagnostic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Rubella Diagnostic Testing Market Growth Rate Analysis
• 5.4. Global Rubella Diagnostic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Rubella Diagnostic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Rubella Diagnostic Testing Total Addressable Market (TAM)

6. Rubella Diagnostic Testing Market Segmentation

• 6.1. Global Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Latex Agglutination
• Liver Function Tests
• Enzyme Immunoassay (EIA)
• Radioimmunoassay (RIA)
• Fluorescent Immunoassay (FIA)
• Other Diagnostic Techniques
• 6.2. Global Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neonates
• Teenagers
• Adults
• 6.3. Global Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Cancer Diagnostic Centers
• Ambulatory Surgical Centers
• Other End Users
• 6.4. Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Latex Agglutination, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Qualitative Latex Agglutination Tests
• Quantitative Latex Agglutination Tests
• Rapid Latex Agglutination Kits
• 6.5. Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Liver Function Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serum Bilirubin Tests
• Alanine Aminotransferase (ALT) Tests
• Aspartate Aminotransferase (AST) Tests
• Alkaline Phosphatase (ALP) Tests
• Other Liver Enzyme Tests
• 6.6. Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Enzyme Immunoassay (EIA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct EIA
• Indirect EIA
• Sandwich EIA
• Competitive EIA
• 6.7. Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Radioimmunoassay (RIA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard RIA
• Modified RIA
• Single-Antibody RIA
• 6.8. Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Fluorescent Immunoassay (FIA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct FIA
• Indirect FIA
• Sandwich FIA
• 6.9. Global Rubella Diagnostic Testing Market, Sub-Segmentation Of Other Diagnostic Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction (PCR)
• Nucleic Acid Amplification Tests (NAAT)
• Microplate-Based Assays
• Western Blotting

7. Rubella Diagnostic Testing Market Regional And Country Analysis

• 7.1. Global Rubella Diagnostic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Rubella Diagnostic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Rubella Diagnostic Testing Market

• 8.1. Asia-Pacific Rubella Diagnostic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Rubella Diagnostic Testing Market

• 9.1. China Rubella Diagnostic Testing Market Overview
• 9.2. China Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Rubella Diagnostic Testing Market

• 10.1. India Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Rubella Diagnostic Testing Market

• 11.1. Japan Rubella Diagnostic Testing Market Overview
• 11.2. Japan Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Rubella Diagnostic Testing Market

• 12.1. Australia Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Rubella Diagnostic Testing Market

• 13.1. Indonesia Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Rubella Diagnostic Testing Market

• 14.1. South Korea Rubella Diagnostic Testing Market Overview
• 14.2. South Korea Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Rubella Diagnostic Testing Market

• 15.1. Western Europe Rubella Diagnostic Testing Market Overview
• 15.2. Western Europe Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Rubella Diagnostic Testing Market

• 16.1. UK Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Rubella Diagnostic Testing Market

• 17.1. Germany Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Rubella Diagnostic Testing Market

• 18.1. France Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Rubella Diagnostic Testing Market

• 19.1. Italy Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Rubella Diagnostic Testing Market

• 20.1. Spain Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Rubella Diagnostic Testing Market

• 21.1. Eastern Europe Rubella Diagnostic Testing Market Overview
• 21.2. Eastern Europe Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Rubella Diagnostic Testing Market

• 22.1. Russia Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Rubella Diagnostic Testing Market

• 23.1. North America Rubella Diagnostic Testing Market Overview
• 23.2. North America Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Rubella Diagnostic Testing Market

• 24.1. USA Rubella Diagnostic Testing Market Overview
• 24.2. USA Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Rubella Diagnostic Testing Market

• 25.1. Canada Rubella Diagnostic Testing Market Overview
• 25.2. Canada Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Rubella Diagnostic Testing Market

• 26.1. South America Rubella Diagnostic Testing Market Overview
• 26.2. South America Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Rubella Diagnostic Testing Market

• 27.1. Brazil Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Rubella Diagnostic Testing Market

• 28.1. Middle East Rubella Diagnostic Testing Market Overview
• 28.2. Middle East Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Rubella Diagnostic Testing Market

• 29.1. Africa Rubella Diagnostic Testing Market Overview
• 29.2. Africa Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Rubella Diagnostic Testing Market Competitive Landscape And Company Profiles

• 30.1. Rubella Diagnostic Testing Market Competitive Landscape
• 30.2. Rubella Diagnostic Testing Market Company Profiles
  • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Rubella Diagnostic Testing Market Other Major And Innovative Companies

• 31.1. bioMerieux S.A.
• 31.2. Bio-Rad Laboratories Inc.
• 31.3. Ortho-Clinical Diagnostics Inc.
• 31.4. DiaSorin S.p.A.
• 31.5. Meridian Bioscience Inc.
• 31.6. Fortress Diagnostics Ltd.
• 31.7. Mylab Discovery Solutions Pvt. Ltd.
• 31.8. MP Biomedicals LLC
• 31.9. CTK Biotech Inc.
• 31.10. ZEUS Scientific Inc.
• 31.11. Creative Diagnostics
• 31.12. Arlington Scientific Inc.
• 31.13. AccuBioTech Co. Ltd.
• 31.14. Intec Products Inc.
• 31.15. Vitrosens Biotechnology Ltd.

32. Global Rubella Diagnostic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Rubella Diagnostic Testing Market

34. Recent Developments In The Rubella Diagnostic Testing Market

35. Rubella Diagnostic Testing Market High Potential Countries, Segments and Strategies

• 35.1 Rubella Diagnostic Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Rubella Diagnostic Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Rubella Diagnostic Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer